Zolmitriptan et Impuretés

Impurity Zolmitriptan USP Related Compound A
Stability Hygroscopic
Applications A metabolite of Zolmitriptan (Z639000). Zolmitriptan USP Related Compound A.
References Chen, J., et al.: J. Pharm. Biomed. Anal., 35, 639 (2004), Srinivasu, M., et al.: J. Pharm. Biomed. Anal., 37, 453 (2005),

Applications Zolmitriptan (Z639000) impurity.

Applications Zolmitriptan is a serotonin 5HTID-receptor agonist and used to treat migraine (1,2,3).
References (1) Glen, R.C., et al.: J. Med. Chem., 38, 3566 (1995)(2) Seaber, E., et al.: Brit. J. Clin. Pharmacol., 41, 141 (1996)(3) Tepper, S.J., et al.: Curr. Med. Res. Opin., 15, 254 (1999)

Impurity Zolmitriptan USP Related Compound E
Applications A metabolite of Zolmitriptan. Zolmitriptan USP Related Compound E.
References Forrester, L., et al.: Biochem. J., 281, 359 (1992), Newton, D., et al.: Drug Metab. Dis., 23, 154 (1995), Dixon, R., et al.: Clin. Drug Invest., 15, 515 (1998), Whale, R., et al.: Psychopharmacology, 145, 223 (1999), Wild, M., et al.: Xenobiotica, 29, 847 (1999),

Impurity Zolmitriptan USP Related Compound G
Applications An intermediate of Zolmitriptan, as a novel inhibitor of the cytochrome P-450 enzyme aromatase. Zolmitriptan USP Related Compound G.
References Ahmed, S., et al.: Bioorg. Med. Chem. Lett., 5, 2789(1995), Ahmed, S., et al.: Drug. Des. Discov., 15, 239 (1998), Brodie, A., et al.: Steroids, 65, 171 (2000),

Stability Hygroscopic
Applications The indole acetic acid metabolite of Zolmitriptan (Z639000) formed by human hepatocytes.
References Wild, M.J. et al.: Xenobiotica, 29, 847 (1999);

Applications Tryptamine is a monoamine alkaloid found in plants. Tryptamine is commonly used in the preparation of biologically active compounds such as neurotransmitters and psychedelics.
References Nichols, D. E., et al.: Curr. Top. Behav. Neurosci., 36, 1(2018); Espinoza, S., et al.: Top. Med. Chem., 23, 175 (2017)

Stability Hygroscopic
Applications A Serotonin 5HTID-receptor agonist.
References Glen, R.C., et al.: J. Med. Chem., 38, 3566 (1995), Seaber, E., et al.: Brit. J. Clin. Pharmacol., 41, 141 (1996), Tepper, S.J., et al.: Curr. Med. Res. Opin., 15, 254 (1999)